Quest Diagnostics (DGX): Politician trade (Senate), $1K

$1,001–$15,000
Reported range · official band, not an exact amount: 113 days
Disclosure lag

Traded: Mar 30, 2026
Disclosed: Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 28, 2025Federal contract · $2.7M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.75M obligated to date
Feb 10, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
Feb 10, 2026InsiderOfficer sold ~$1.16M of DGX shares in the open market
Feb 13, 2026Insider · 1 personInsiders: 5 sales (~$5.4M)
Feb 19, 2026Insider · 3 peopleInsiders: 3 sales (~$717K)
Mar 2, 2026InsiderCEO sold ~$2.13M of DGX shares in the open market
Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$326K)
Mar 4, 2026InsiderOfficer sold ~$538K of DGX shares in the open market
Mar 5, 2026Insider · 3 peopleInsiders: 3 sales (~$2.5M)
Mar 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, the Board of Directors (the “Board”) of Quest Diagnostics Incorporated (the “Company”), after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director.”
Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
Mar 27, 2026CongressDisclosed purchase of DGX — reported range $1,001 - $15,000
Mar 30, 2026 · this disclosureCongressDisclosed purchase of DGX — reported range $1,001 - $15,000

What came next

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Quest Diagnostics

For Quest Diagnostics, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 12 fund holdings reports (13F) and 7 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

Other disclosures at Quest Diagnostics

Everything OQRO holds on this company is on its DGX page.

Quest Diagnostics (DGX)Sen. Alan Armstrong disclosed a purchase $1K–$15K